Alexandros Bouras

Dr. Alexandros Bouras


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
BRBenjamin Rodriguez
Benjamin Rodriguez
DRDaniel Rivera
Daniel Rivera
JZJack Y. Zhang
Jack Y. Zhang
CBCole Brown
Cole Brown
TYTirone Young
Tirone Young
CHConstantinos G. Hadjipanayis
Constantinos G. Hadjipanayis
Magnetic hyperthermia therapy (MHT) is a re-emerging treatment modality for brain tumors where magnetic nanoparticles (MNPs) are locally delivered to the brain and then activated with an external alternating magnetic field (AMF) to generate localized heat at a site of interest. Due to the recent advancements in technology and theory surrounding the intervention, clinical and pre-clinical trials have demonstrated that MHT may enhance the effectiveness of chemotherapy and radiation therapy (RT) for the treatment of brain tumors. The future clinical success of MHT relies heavily on designing MNPs optimized for both heating and imaging, developing reliable methods for the local delivery of MNPs, and designing AMF systems with integrated magnetic particle imaging (MPI) for use in humans. However, despite the progression of technological development, the clinical progress of MHT has been underwhelming. This review aims to summarize the current state-of-the-art of MHT and offers insight into the current barriers and potential solutions for moving MHT forward.

4 January 2023 in Cancers
Verified
Journal Article
Open access
PDF file
ASAnirudh Sharma
Anirudh Sharma
AJAvesh Jangam
Avesh Jangam
JSJulian Low Yung Shen
Julian Low Yung Shen
AAAiman Ahmad
Aiman Ahmad
NANageshwar Arepally
Nageshwar Arepally
AAAnilchandra Attaluri
Anilchandra Attaluri
We present in vivo validation of an automated magnetic hyperthermia therapy (MHT) device that uses real-time temperature input measured at the target to control tissue heating. MHT is a thermal therapy that uses heat generated by magnetic materials exposed to an alternating magnetic field. For temperature monitoring, we integrated a commercial fiber optic temperature probe containing four gallium arsenide (GaAs) temperature sensors. The controller device used temperature from the sensors as input to manage power to the magnetic field applicator. We developed a robust, multi-objective, proportional-integral-derivative (PID) algorithm to control the target thermal dose by modulating power delivered to the magnetic field applicator. The magnetic field applicator was a 20 cm diameter Maxwell-type induction coil powered by a 120 kW induction heating power supply operating at 160 kHz. Finite element (FE) simulations were performed to determine values of the PID gain factors prior to verification and validation trials. Ex vivo verification and validation were conducted in gel phantoms and sectioned bovine liver, respectively. In vivo validation of the controller was achieved in a canine research subject following infusion of magnetic nanoparticles (MNPs) into the brain. In all cases, performance matched controller design criteria, while also achieving a thermal dose measured as cumulative equivalent minutes at 43 °C (CEM43) 60 ± 5 min within 30 min.

27 April 2026 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
JRJheremy S. Reyes
Jheremy S. Reyes
TATimoteo Almeida
Timoteo Almeida
ABAlexandros Bouras
Alexandros Bouras
JMJoseph Mettenburg
Joseph Mettenburg
ANAjay Niranjan
Ajay Niranjan
CHConstantinos G. Hadjipanayis
Constantinos G. Hadjipanayis

24 April 2024 in Micromachines
Verified
Journal Article
Open access
PDF file
FRFrederika Rentzeperis
Frederika Rentzeperis
DRDaniel Rivera
Daniel Rivera
JZJack Y. Zhang
Jack Y. Zhang
CBCole Brown
Cole Brown
TYTirone Young
Tirone Young
CHConstantinos G. Hadjipanayis
Constantinos G. Hadjipanayis
Magnetic hyperthermia therapy (MHT) is a promising treatment modality for brain tumors using magnetic nanoparticles (MNPs) locally delivered to the tumor and activated with an external alternating magnetic field (AMF) to generate antitumor effects through localized heating. Magnetic particle imaging (MPI) is an emerging technology offering strong signal-to-noise for nanoparticle localization. A scoping review was performed by systematically querying Pubmed, Scopus, and Embase. In total, 251 articles were returned, 12 included. Articles were analyzed for nanoparticle type used, MHT parameters, and MPI applications. Preliminary results show that MHT is an exciting treatment modality with unique advantages over current heat-based therapies for brain cancer. Effective application relies on the further development of unique magnetic nanoparticle constructs and imaging modalities, such as MPI, that can enable real-time MNP imaging for improved therapeutic outcomes.